Enjoy complimentary customisation on priority with our Enterprise License!
The cancer diagnostics market size is forecast to increase by USD 17.74 billion at a CAGR of 13.64% between 2023 and 2028. The market is experiencing significant growth due to the high prevalence of various types of cancer, including cervical and blood cancer. The increasing research and development in this field, coupled with advances in technology, are driving market growth. Technologies such as biopsy, endoscopy, X-rays, ultrasound, computed tomography (CT), SPECT, magnetic resonance imaging (MRI), positron emission tomography (PET), and optical imaging are increasingly being used for cancer diagnosis. However, the high cost of developing companion diagnostics is a major challenge for market growth. For instance, the development of personalized diagnostics for specific types of cancer requires significant investment in research and development. Despite this challenge, the market is expected to continue growing due to the increasing demand for early and accurate cancer diagnosis.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.